The new Abbott Laboratories (ABT) begins its 125th year focused on sales of medical devices, established generic drugs, diagnostic tests and nutritionals with an eye on emerging markets led by Russia, China and Brazil that are free of austerity measures sweeping Europe as well as the Affordable Care Act here in the U.S.
